Yati Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 14 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 M
- Revenue Growth 62.52%
- Profit Growth 137.07%
- Ebitda 533.48%
- Net Worth 46.02%
- Total Assets 40.88%
About Yati Pharmaceuticals
Yati Pharmaceuticals Private Limited (YPPL) is a Private Limited Indian Non-Government Company incorporated in India on 31 August 2010 and has a history of 14 years and five months. Its registered office is in Muzaffarnagar, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.00 M.
Deependra Malik, Bhupendra Singh, Akhilesh Singh, and One other member serve as directors at the Company.
Company Details
-
Location
Muzaffarnagar, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100UP2010PTC063660
-
Company No.
063660
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
31 Aug 2010
-
Date of AGM
29 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Yati Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deependra Malik
|
Whole-Time Director | 31-Aug-2010 | Current |
|
Bhupendra Singh
|
Whole-Time Director | 29-Oct-2011 | Current |
|
Akhilesh Singh
|
Whole-Time Director | 26-Dec-2011 | Current |
|
Anil Bhatnagar
|
Director | 29-Oct-2011 | Current |
Financial Performance of Yati Pharmaceuticals.
Yati Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 62.52% increase. The company also saw a substantial improvement in profitability, with a 137.07% increase in profit. The company's net worth Soared by an impressive increase of 46.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Yati Pharmaceuticals?
In 2021, Yati Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Pankon Biotech Solutions Private LimitedAnil Bhatnagar is a mutual person
Charges (Loans)
₹2.00 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Feb 2020 | State Bank Of India | ₹2.00 M | Open |
How Many Employees Work at Yati Pharmaceuticals?
Yati Pharmaceuticals has a workforce of 35 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Yati Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Yati Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
